Bhavna Malik

Bhavna Malik is a Senior Research Scientist in Discovery Oncology at Gilead Sciences, based in San Mateo, California.1 She is a highly motivated cancer biologist with extensive experience in oncology target discovery and validation, as well as preclinical small molecule drug discovery.1

Professional Experience

Bhavna's career in the pharmaceutical industry includes:

• Senior Research Scientist at Gilead Sciences (October 2020 - Present)1
• Senior Research Investigator at Bristol-Myers Squibb (July 2018 - October 2020)1
• Scientist, Oncology Discovery at The Janssen Pharmaceutical Companies of Johnson & Johnson (April 2017 - July 2018)1

Expertise

Bhavna has demonstrated skills in:

• Developing and establishing biochemical and cell-based assays
• Assessing drug target engagement ex-vivo and in-vivo
• Evaluating and characterizing the mechanism of action of small molecule inhibitors1

She has also been involved in identifying new targets, leading hit finding, hit-to-lead, and lead nomination efforts in drug discovery.1

Education

Bhavna holds the following degrees:

• Ph.D. in Molecular and Cellular Biochemistry from Loyola University Chicago Stritch School of Medicine (2008 - 2013)1
• Master's degree in Medical Microbiology and Bacteriology from Panjab University (2003 - 2005)1

Research Contributions

As a Postdoctoral Research Fellow at the University of Michigan (June 2013 - February 2015), Bhavna made significant contributions to cancer research:

• Discovered and validated the role of the Menin-MLL complex as a therapeutic target in leukemia and hepatocellular carcinoma
• Led a cross-functional team to develop and optimize small molecule inhibitors of Menin-MLL interaction1

Bhavna Malik is known for her excellent communication and leadership skills, as well as her ability to work effectively in a matrix environment.1